Patanjali didn’t mention Covid-19 drug in license application: Uttarakhand official


Patanjali didn’t mention Covid-19 drug in license application: Uttarakhand official

Patanjali Ayurved Ltd, the firm encouraged by yoga guru Ramdev, Patanjali didn’t mention that it was developing a medication for the coronavirus disorder (Covid-19) while still applying for a license, an official of the Uttarakhand government stated, news agency ANI reported Wednesday.
Hours after Ramdev established the drugs, the government on Tuesday sought clarification from Patanjali on its promise of having developed a remedy for Covid-19 and requested it to stop marketing the product before the claim is confirmed.

The Uttarakhand government, that is the state licensing authority to its Haridwar-based Patanjali, accepted the production and marketing for those drugs.

“According to Patanjali’s program, we issued a license. Coronavirus wasn’t mentioned by them. We just approved the license for resistance booster, fever and cough,” that a licencing officer of this nation’s Ayurveda division has been quoted as saying from ANI.
“We will issue them a note asking how they obtained permission to produce the kit (such as Covid-19),” the official added.

Patanjali had promised that the drugs are made in affiliation with the privately-owned National Institute of Medical Science (NIMS) at Jaipur. But, no testing information was released by it.\

Earlier in the afternoon, AYUSH Union Shripad Naik stated that Patanjali’s drugs will be supplied a go-ahead just after the government appears into the report delivered by the business.

“it is a fantastic thing which Baba Ramdev has contributed a new medication to the nation but according to principle, it must come to AYUSH ministry ” Naik said, based on ANI.
“They said they have delivered a report. We are going to look in to it and consent will be given after viewing the record,” Naik added.